|
HY-13510-1mL
|
MedChemexpress LLC
|
Cutamesine dihydrochloride [CAS 165377-44-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-1mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-10mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-100mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-25mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-5mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-50mg
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-116042-1mL
|
MedChemexpress LLC
|
FSCPX [CAS 156547-56-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-10mg
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-100mg
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-25mg
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-5mg
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-50mg
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101396-1mL
|
MedChemexpress LLC
|
ICA-069673 [CAS 582323-16-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1256C-5mg
|
MedChemexpress LLC
|
JMV 449 (acetate) [CAS 141863-45-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-1mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-10mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-25mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108591-5mg
|
MedChemexpress LLC
|
L-364,373 [CAS 103342-82-1]
|
|
Neuroscience-Neuromodulation
|
|
